Exercise Can Reduce Depression, Anxiety Symptoms
via HealthDayTUESDAY, Feb. 17, 2026 -- Exercise can reduce depression and anxiety symptoms, according to a study published online Feb. 10 in The British Journal of Sports Medicine.
Neil Richard Munro, from James Cook University in Queensland, Australia, and colleagues conducted a meta-analysis of randomized controlled trials to examine the effects of exercise on depression and anxiety across all population groups, including children and adults with both clinically diagnosed and subclinical symptoms. Sixty-three studies with 79,551 participants were included.
The researchers found that exercise reduced depression and anxiety symptoms (standardized mean differences, –0.61 and –0.47, respectively); the most substantial impact on depression and anxiety symptoms was seen for aerobic exercise. By population group, the greatest benefits for depression were seen in adults aged 18 to 30 years and postnatal women. There was an association for greater reductions in depression with exercise in group and supervised settings. The strongest association with anxiety reduction was seen for exercise of shorter duration and at lower intensity.
"Exercise is an accessible and cost-effective treatment option for depression and anxiety, so these findings must be translated into clear, actionable guidelines for ensuring widespread adoption and long-term impact," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-18 13:38
Read more
- Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
- Harmony Biosciences Receives U.S. Food and Drug Administration Approval for Wakix (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
- Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL
- NIH Halts Arm of Clinical Trial Evaluating a Potential Stroke Treatment
- FDA Expands Tater Tot Recall Tied to Possible Plastic Contamination
- U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions